Trial Outcomes & Findings for Clinical Outcomes Mandible: Buffered 1% vs. Non-Buffered 1% Lidocaine (NCT NCT03127943)

NCT ID: NCT03127943

Last Updated: 2019-02-06

Results Overview

Subjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

24 participants

Primary outcome timeframe

Every 30 minutes up to 120 minutes Total

Results posted on

2019-02-06

Participant Flow

Participant milestones

Participant milestones
Measure
Buffered 1% Lidocaine, Then Non-Buffered 1% Lidocaine
At each treatment visit participants were injected to block the Inferior alveolar, Lingual and Buccal nerves.
Non-Buffered 1% Lidocaine, Then Buffered 1% Lidocaine
At each treatment visit participants were injected to block the Inferior alveolar, Lingual and Buccal nerves.
First Intervention
STARTED
12
12
First Intervention
COMPLETED
12
12
First Intervention
NOT COMPLETED
0
0
Washout (1 Week)
STARTED
12
12
Washout (1 Week)
COMPLETED
12
12
Washout (1 Week)
NOT COMPLETED
0
0
Second Intervention
STARTED
12
12
Second Intervention
COMPLETED
12
12
Second Intervention
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Clinical Outcomes Mandible: Buffered 1% vs. Non-Buffered 1% Lidocaine

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
All Study Participants
n=24 Participants
Participants who were to receive either Buffered 1% lidocaine or Non-Buffered 2% Lidocaine
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
24 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Age, Continuous
24 years
n=5 Participants
Sex: Female, Male
Female
13 Participants
n=5 Participants
Sex: Female, Male
Male
11 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
21 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
Region of Enrollment
United States
24 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Every 30 minutes up to 120 minutes Total

Subjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no

Outcome measures

Outcome measures
Measure
Buffered 1% Lidocaine, Then Non-Buffered 1% Lidocaine
n=24 Participants
All subjects who received Buffered 1% Lidocaine
Non-buffered 1% Lididocaine, the Buffered 1% Lidocaine
n=24 Participants
All subjects who received Non\_buffered Lidocaine
Mean Time to Pulpal Response After Mandibular Molar Anesthesia
100 minutes
Standard Deviation 37.2
106 minutes
Standard Deviation 41.5

PRIMARY outcome

Timeframe: 30 minute intervals up to 120 minutes

Subjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no

Outcome measures

Outcome measures
Measure
Buffered 1% Lidocaine, Then Non-Buffered 1% Lidocaine
n=24 Participants
All subjects who received Buffered 1% Lidocaine
Non-buffered 1% Lididocaine, the Buffered 1% Lidocaine
n=24 Participants
All subjects who received Non\_buffered Lidocaine
Mean Time to Pulpal Response After Mandibular Canine Anesthesia
81.3 minutes
Standard Deviation 44.7
97.5 minutes
Standard Deviation 43.6

Adverse Events

Buffered 1% Lidocaine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Non-Buffered 1% Lidocaine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Raymond P. White Jr DDS, PhD

UNC Department of Oral and Maxillofacial Surgery

Phone: 919-537-3944

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place